Leo Pharma

This study tested a cream called delgocitinib for people with moderate to severe chronic hand eczema that didn't improve enough with standard steroid creams. Over 360 Chinese adults and teenagers applied the cream twice daily for 16 weeks to see if it could clear or nearly clear …

This study tested if a higher, adjustable dose of the psoriasis medication brodalumab works better for people who weigh over 120 kg. It compared this adjusted dose to the standard dose over 52 weeks. The goal was to see if the higher dose could improve skin clearance and quality …

This completed study tested four different doses of an experimental drug called LEO 138559 (temtokibart) against a placebo in 262 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to find the most effective and safest dose to reduce the severity and extent o…

This completed Phase 3 trial tested whether tralokinumab injections every two weeks could safely and effectively treat moderate-to-severe atopic hand eczema. The study involved 235 adults whose hand eczema did not improve enough with standard creams and who also had eczema elsewh…

This was a very small, early-stage study to see if a single injection of an experimental drug called LEO 158968 could safely reduce pain from sudden gout attacks. It involved just 6 people who were experiencing a painful gout flare in one of their joints. The main goal was to che…